Whole-body MRI for initial staging, early response assessment and restaging after completion of therapy in pediatric Hodgkin lymphoma. - Whole-body MRI in pediatric Hodgkin lymphoma

niversitair Medisch Centrum Utrecht0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•- male or female patients
•- age: 8-18 years
•- histologically proven Hodgkin's disease
•- enrolled in the EuroNet-PHL-C1 trial
•- patients scheduled for a FDG-PET/CT or CT of the body for initial staging, early response assessment or restaging at end of treatment
•- the participant must willingly give written informed consent prior to the start of the study and before each MRI
•- Whole-body MRI has to be performed within 15 days before or after FDG-PET/CT or CT, and before therapy has been started.

•- patients with a general contraindication for MRI (including cardiovascular pacemakers, claustrofobia)
•- patients who have had a previous malignancy
•- patients who are pregnant or nursing
•- patients in whom therapy has already started after FDG-PET/CT and before MRI could be performed
•-Apparent signs of resistance

发起方

niversitair Medisch Centrum Utrecht